Recall issued for aspiration system by Q’Apel Medical

Apr 24, 2025 - 03:59 PM
fda-alert-recall-compounded-drugs

The Food and Drug Administration has identified a of Q’Apel Medical 072 Aspiration System after the company submitted three device event reports that included a tip detachment, a vessel rupture and a vasospasm.

Related News Articles

Headline
FDA issues alerts on certain catheters produced by BD, Conavi
The Food and Drug Administration has issued alerts for issues with certain catheters made by BD and Conavi. BD identified an increase in material fatigue…
Headline
FDA recalls Medtronic Aortic Root Cannulas 
The Food and Drug Administration has identified a Class I recall of Medtronic Aortic Root Cannulas due to a risk of unexpected loose material in the male luer…
Blog
Can Collaborative Efforts to Improve Device Design Improve Safety?
Public
During World War II, the U.S. Army Air Corps depended on its B-17 bombers to inflict incredible damage against the Axis powers in Europe. These “Flying…
Headline
Recall issued for Becton, Dickinson and Company infusion pump adapters
The Food and Drug Administration has identified a Class I recall of Becton, Dickinson and Company BD Alaris Systems Manager and BD Care Coordination Engine…
Headline
FDA issues recall on Medtronic embolization devices
The Food and Drug Administration has identified a Class I recall of Medtronic Neurovascular 027 Compatible Pipeline Vantage Embolization Devices due to reports…
Headline
Baxter recalls Spectrum infusion pumps 
The Food and Drug Administration March 5 announced that Baxter Healthcare Corporation recalled its Spectrum infusion pumps due to the potential for missing…